Covered recipient · General Payments record
TARA FARAHVASH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,786.74
- Reported across 192 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.83 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $67.39 | 3 |
| Acerta Pharma LLC | $60.64 | 3 |
| Novo Nordisk AS | $45.51 | 2 |
| PFIZER INC. | $42.57 | 2 |
| ABBVIE INC. | $41.11 | 2 |
| GlaxoSmithKline, LLC. | $21.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.84 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125278401 | CMS |
| Abbott Laboratories | $24.49 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125278403 | CMS |
| Abbott Laboratories | $19.06 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125278405 | CMS |
| ABBVIE INC. | $14.80 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709585 | CMS |
| ABBVIE INC. | $26.31 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709587 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.64 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104427089 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.66 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105497649 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.34 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105441234 | CMS |
| GlaxoSmithKline, LLC. | $21.61 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116491375 | CMS |
| Novo Nordisk Inc | $22.25 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097269461 | CMS |
| Novo Nordisk Inc | $23.26 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097454636 | CMS |
| PFIZER INC. | $18.20 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131620754 | CMS |
| PFIZER INC. | $24.37 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131869016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.